Medicare Enrolled
Dr. Ajay Mhatre, M.D.
Internal Medicine · Panama City, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mhatre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mhatre?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mhatre
Dr. Ajay Mhatre is an internal medicine specialist in Panama City, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mhatre performed 5,840 Medicare services across 4,241 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mhatre received a total of $28,184 from 56 pharmaceutical and/or device companies across 509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mhatre is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in FL
$28,184 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 112316 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗5,840
Medicare services
Top 6% in FL for internal medicine
4,241
Unique beneficiaries
$125
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~307 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,459 | $95 | $226 |
| Regadenoson injection (Lexiscan) for heart stress test | 840 | $28 | $36 |
| Electrocardiogram (EKG), 12-lead | 532 | $11 | $60 |
| Hospital follow-up visit, moderate complexity | 435 | $62 | $160 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 325 | $59 | $77 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 281 | $50 | $245 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 208 | $313 | $400 |
| Echocardiogram, transthoracic | 176 | $144 | $960 |
| New patient office visit (45-59 min) | 172 | $121 | $350 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 162 | $329 | $1,500 |
| Initial hospital admission, moderate complexity | 141 | $103 | $300 |
| Office visit, established patient (20-29 min) | 114 | $67 | $150 |
| Ultrasound of both sides of head and neck blood flow | 110 | $139 | $575 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 104 | $2,091 | $4,800 |
| Nuclear medicine study of heart muscle blood flow by pet | 104 | $139 | $390 |
| Electrocardiogram (ecg) 2-day continuous | 52 | $13 | $60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 52 | $138 | $550 |
| Ultrasound of leg arteries or artery grafts | 51 | $178 | $550 |
| Injection, aminophyllin, up to 250 mg | 51 | $2 | $2 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 49 | $14 | $60 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 49 | $178 | $1,400 |
| Electrocardiogram (ecg) 2-day continuous with report | 40 | $25 | $45 |
| Ultrasound of heart, follow-up | 33 | $70 | $300 |
| Injection, perflutren lipid microspheres, per ml | 32 | $35 | $56 |
| Initial hospital admission, high complexity | 30 | $135 | $425 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 28 | $86 | $350 |
| New patient office visit (30-44 min) | 27 | $88 | $230 |
| Hospital follow-up visit, high complexity | 24 | $94 | $240 |
| Review by radiologist of abdominal aorta image | 22 | $54 | $150 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 22 | $19 | $70 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 21 | $85 | $350 |
| Review by radiologist of arm or leg artery image | 20 | $66 | $140 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 19 | $827 | $4,089 |
| Office visit, established patient (10-19 min) | 16 | $41 | $120 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 15 | $66 | $200 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $2 | $110 |
| Coronary stent placement | 11 | $479 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
32.0% medium
64.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,184
Total received (2018-2024)
Avg $4,026/year across 7 years
Top 3% in FL for internal medicine
56
Companies
509
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,904 (52.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,930 (45.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$350 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,869
2023
$1,063
2022
$1,256
2021
$3,511
2020
$1,457
2019
$3,938
2018
$14,091
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$11,886
Medtronic Vascular, Inc.
$2,576
EKOS Corporation
$1,858
AngioDynamics, Inc.
$1,824
Penumbra, Inc.
$781
ShockWave Medical, Inc
$776
Cardiovascular Systems Inc.
$671
Terumo Medical Corporation
$583
Avinger Inc.
$522
Amgen Inc.
$475
Merck Sharp & Dohme LLC
$436
E.R. Squibb & Sons, L.L.C.
$383
Boston Scientific Corporation
$382
Novartis Pharmaceuticals Corporation
$365
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$326
ORGANOGENESIS INC.
$326
Biosense Webster, Inc.
$316
Inari Medical, Inc.
$309
Cardinal Health 200, LLC
$284
Medtronic, Inc.
$272
Janssen Pharmaceuticals, Inc
$266
PFIZER INC.
$223
Endologix LLC
$208
ABIOMED
$198
AstraZeneca Pharmaceuticals LP
$195
Philips Electronics North America Corporation
$185
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
Bard Peripheral Vascular, Inc.
$133
BTG International, Inc.
$125
BOSTON SCIENTIFIC CORPORATION
$113
Endologix, Inc.
$109
Alnylam Pharmaceuticals Inc.
$102
Chiesi USA, Inc.
$82
SANOFI-AVENTIS U.S. LLC
$72
Bayer HealthCare Pharmaceuticals Inc.
$55
Gilead Sciences, Inc.
$54
Shockwave Medical, Inc
$54
Esperion Therapeutics, Inc.
$49
W. L. Gore & Associates, Inc.
$48
DePuy Synthes Sales Inc.
$46
CVRx, Inc.
$38
Biocompatibles, Inc.
$31
Walk Vascular, LLC
$27
Siemens Medical Solutions USA, Inc.
$25
Merck Sharp & Dohme Corporation
$25
Kerecis Limited
$24
HARTMANN USA, INC.
$22
Medtronic USA, Inc.
$21
BARD PERIPHERAL VASCULAR, INC.
$19
Regeneron Healthcare Solutions, Inc.
$19
Organogenesis Inc.
$16
Kiniksa Pharmaceuticals International, plc
$16
Cardinal Health 200 LLC
$15
Amarin Pharma Inc.
$14
Tactile Systems Technology Inc
$13
KCI USA, Inc.
$12
Top 3 companies account for 57.9% of total payments
Associated products mentioned in payments ›
(6554) Peripheral Vascular Undivided · (792) Multi Modality IVUS Other Systems · ADAPTIVESTIM · ANDEXXA · ANGIOJET · AURYON LASER SYSTEM 100-120 VAC · Acunav · Adempas · Arcalyst · Armada 14 percutaneous catheter · Armada 35 percutaneous catheter · Artis Q ceiling · Asahi Fielder coronary guide wire · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BRILINTA · Barostim Neo System · CAMZYOS · CARTO 3 · CLEVIPREX · COREVALVE EVOLUT R · CROME DR MRI SURESCAN · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Carto 3 System · Claria MRI · ClosureFast · Confirm Rx · Coronary Orbital Atherectomy System · Diamondback Peripheral · EKOSONIC · ELIQUIS · EMBOTRAP II Revascularization Device · ENSITE · ENTRESTO · ESPRIT · Emboshield NAV6 system · Endurant · Ensite Cardiac Mapping System · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 2 · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · FreeStyle Libre blood glucose Flash Monitoring System · GENERAL - ATHERECTOMY · GENERAL - VASCULAR INTERVENTION · GENERAL BRADY · GLIDESHEATH SLENDER · GORE VIABAHN VBX Balloon Expandable Endo · Glidesheath · HawkOne · Hi-Torque Command guide wire · IN.PACT Admiral · Image Guided Therapy Devices _ Peripheral · Impella · Indigo System · JARDIANCE · JETi Peripheral Catheter · KENGREAL · Kerecis Omega3 SurgiClose · Kerendia · LEQVIO · LUTONIX · LifeVest · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MynxGrip Vascular Closure Device · NAVICROSS · NEXLETOL · Navicross · ONPATTRO · Ovation · PANTHERIS · PRALUENT · Pacemakers · Penumbra System · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · Puraply · Quadra Assura CRT Defibrillator · Repatha · Resolute · S · S.M.A.R.T. Self-Expanding Nitinol Stent · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SNAP · SYMPLICITY G3 · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · SilverHawk · Supera peripheral stent system · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Torus Stent Graft System · VARITHENA · VENOUS WALLSTENT · VERQUVO · VYNDAQEL · Vascepa · VenaSeal · WATCHMAN FLX · XARELTO · Zetuvit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in FL.
Equivalent to $483 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
51
Per 100K population
28.1
County median income
$70,188
Nearest hospital
HCA FLORIDA GULF COAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mhatre is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), with low-engagement industry engagement in the top 3% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mhatre experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mhatre performed 1,459 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mhatre receive payments from pharmaceutical companies?
Yes. Dr. Mhatre received a total of $28,184 from 56 companies across 509 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mhatre's costs compare to other internal medicine physicians in Panama City?
Dr. Mhatre's average Medicare payment per service is $125. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mhatre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Panama City
Browse internal medicine physicians in Panama City ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
EKOS Corporation Payments to Doctors
See all physicians who received payments from EKOS Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology